About
Technology
Issues
FAQ
Links
Official Page
Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.